CEO, Nigel Theobald, responds to investor questions from the October 2024 Corporate Presentation.
View the full slide deck here.
Share your feedback
Questions (0)
Your question will be sent privately to Thalia Therapeutics. The company may choose to make this question public.
Start the conversation
Ask Thalia Therapeutics a question about this announcement.
Discover
